Denise Dignam M.'s Insider Trades & SAST Disclosures
Denise Dignam M.'s most recent trade in Chemours Company was a trade of 367,866 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Denise Dignam M..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 367,866 | 367,866 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 353,717 | 353,717 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 106,421 | 177,211 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.95 per share. | 01 Mar 2025 | 4,818 | 70,790 (0%) | 0% | 14.9 | 72,029 | Common Stock |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 956 | 5,969 (0%) | 0% | 0 | Common Stock | |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 1,025 | 5,013 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.31 per share. | 01 Aug 2024 | 303 | 75,608 (0%) | 0% | 23.3 | 7,063 | Common Stock |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 933 | 3,988 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 95,792 | 95,792 | - | - | Performance Stock Option (Right to Buy) | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 92,108 | 92,108 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 34,431 | 75,327 (0%) | 0% | 0 | Common Stock | |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 891 | 3,055 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 9,496 | 43,954 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.88 per share. | 27 Mar 2024 | 3,058 | 40,896 (0%) | 0% | 28.9 | 88,315 | Common Stock |
| Chemours Company | Denise M. Dignam | Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.78 per share. | 01 Mar 2024 | 1,299 | 34,229 (0%) | 0% | 20.8 | 26,993 | Common Stock |
| Kulicke & Soffa Industries... | Denise Dignam M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 853 | 2,164 (0%) | 0% | 0 | Common Stock | |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2023 | 380 | 380 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges